|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brigham and Women's Hospital, Harvard Medical School Boston, MA 02115
With great interest I read the article, "Making Sense of Mucin-Producing Pancreatic Tumors," by Grogan et al. [1]. Nevertheless, I would like to focus your attention to a particular statement made in table 1 of this article. The sex ratio (M-F) for the mucinous cystic neoplasm reported is 9:1. This marked predilection for men is in contrast with other articles published on this subject, which show that mucinous cystic tumors occur almost exclusively in women [2,3,4,5].
Although I assume this mistake is due to an editing error, I truly believe this incorrect information can mislead inexperienced readers of AJR, especially because this specific clinicopathologic feature is not further discussed in the text.
References
University of Wisconsin Medical School Madison, WI 53792-3252
I thank Dr. Mortelé for his perspicacious attention to our recent article [1]. I apologize for the inadvertent transposition of the numbers in the ratio of female-to-male prevalence of mucinous cystic neoplasms of the pancreas as detailed in table 1 of this article. Dr. Mortelé is quite right in stating that there is a preponderance of women who are at risk for this pancreatic tumor.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |